Literature DB >> 28592549

Emergence of a Staphylococcus aureus Clone Resistant to Mupirocin and Fusidic Acid Carrying Exotoxin Genes and Causing Mainly Skin Infections.

Anastassios Doudoulakakis1, Iris Spiliopoulou2, Nikolaos Spyridis3, Nikolaos Giormezis2, John Kopsidas3, Maria Militsopoulou2, Evangelia Lebessi4, Maria Tsolia3.   

Abstract

Skin and soft tissue infections (SSTIs) caused by mupirocin-resistant Staphylococcus aureus strains have recently increased in number in our settings. We sought to evaluate the characteristics of these cases over a 43-month period. Data for all community-acquired staphylococcal infections caused by mupirocin-resistant strains were retrospectively reviewed. Genes encoding products producing high-level resistance (HLR) to mupirocin (mupA), fusidic acid resistance (fusB), resistance to macrolides and lincosamides (ermC and ermA), Panton-Valentine leukocidin (PVL) (lukS/lukF-PV), exfoliative toxins (eta and etb), and fibronectin binding protein A (fnbA) were investigated by PCRs in 102 selected preserved strains. Genotyping was performed by SCCmec and agr typing, whereas clonality was determined by pulsed-field gel electrophoresis (PFGE) and multilocus sequence typing (MLST). A total of 437 cases among 2,137 staphylococcal infections were recorded in 2013 to 2016; they were all SSTIs with the exception of 1 case of primary bacteremia. Impetigo was the predominant clinical entity (371 cases [84.9%]), followed by staphylococcal scalded skin syndrome (21 cases [4.8%]), and there were no abscesses. The number of infections detected annually increased during the study years. All except 3 isolates were methicillin susceptible. The rates of HLR to mupirocin and constitutive resistance to clindamycin were 99% and 20.1%, respectively. Among the 102 tested strains, 100 (98%) were mupA positive and 97 (95%) were fusB positive, 26/27 clindamycin-resistant strains (96.3%) were ermA positive, 83 strains (81.4%) were lukS/lukF positive, 95 (93%) carried both eta and etb genes, and 99 (97%) were fnbA positive. Genotyping of methicillin-sensitive S. aureus (MSSA) strains revealed that 96/99 (96.7%) belonged to one main pulsotype, pulsotype 1, classified as sequence type 121 (ST121). The emergence of a single MSSA clone (ST121) causing impetigo was documented. Resistance to topical antimicrobials and a rich toxinogenic profile confer to this clone adaptability for spread in the community.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  CC121; MLST; Staphylococcus aureus; children; clone; epidermolysins; exotoxins; fusidic acid; impetigo; mupirocin

Mesh:

Substances:

Year:  2017        PMID: 28592549      PMCID: PMC5527431          DOI: 10.1128/JCM.00406-17

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

Review 1.  Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus.

Authors:  Binh An Diep; Steven R Gill; Richard F Chang; Tiffany HaiVan Phan; Jason H Chen; Matthew G Davidson; Felice Lin; Jessica Lin; Heather A Carleton; Emmanuel F Mongodin; George F Sensabaugh; Françoise Perdreau-Remington
Journal:  Lancet       Date:  2006-03-04       Impact factor: 79.321

2.  High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population.

Authors:  Nina K Antonov; Maria C Garzon; Kimberly D Morel; Susan Whittier; Paul J Planet; Christine T Lauren
Journal:  Antimicrob Agents Chemother       Date:  2015-03-30       Impact factor: 5.191

Review 3.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

4.  Antibacterial resistance, genes encoding toxins and genetic background among Staphylococcus aureus isolated from community-acquired skin and soft tissue infections in France: a national prospective survey.

Authors:  B Lamy; F Laurent; O Gallon; F Doucet-Populaire; J Etienne; J-W Decousser
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-10-14       Impact factor: 3.267

5.  Comparison of molecular typing methods for characterization of Staphylococcus epidermidis: proposal for clone definition.

Authors:  M Miragaia; J A Carriço; J C Thomas; I Couto; M C Enright; H de Lencastre
Journal:  J Clin Microbiol       Date:  2007-11-07       Impact factor: 5.948

6.  Clinical and molecular epidemiology of community-acquired, methicillin-resistant Staphylococcus aureus infections in children in central Greece.

Authors:  I Niniou; S Vourli; E Lebessi; M Foustoukou; A Vatopoulos; D G Pasparakis; D A Kafetzis; M N Tsolia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-07       Impact factor: 3.267

Review 7.  Mupirocin resistance.

Authors:  Jean B Patel; Rachel J Gorwitz; John A Jernigan
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

Review 8.  Seasonality of staphylococcal infections.

Authors:  S Leekha; D J Diekema; E N Perencevich
Journal:  Clin Microbiol Infect       Date:  2012-10       Impact factor: 8.067

9.  Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with Methicillin-resistant S. aureus hospital-acquired infection in the United States.

Authors:  Veronica N Kos; Christopher A Desjardins; Allison Griggs; Gustavo Cerqueira; Andries Van Tonder; Matthew T G Holden; Paul Godfrey; Kelli L Palmer; Kip Bodi; Emmanuel F Mongodin; Jennifer Wortman; Michael Feldgarden; Trevor Lawley; Steven R Gill; Brian J Haas; Bruce Birren; Michael S Gilmore
Journal:  mBio       Date:  2012-05-22       Impact factor: 7.867

10.  The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.

Authors:  Sverre Rørtveit; Dag Harald Skutlaberg; Nina Langeland; Guri Rortveit
Journal:  Scand J Infect Dis       Date:  2014-09-17
View more
  10 in total

Review 1.  Staphylococcal-scalded skin syndrome: evaluation, diagnosis, and management.

Authors:  Alexander K C Leung; Benjamin Barankin; Kin Fon Leong
Journal:  World J Pediatr       Date:  2018-03-05       Impact factor: 2.764

2.  Genomic Epidemiology and Global Population Structure of Exfoliative Toxin A-Producing Staphylococcus aureus Strains Associated With Staphylococcal Scalded Skin Syndrome.

Authors:  Taj Azarian; Eleonora Cella; Sarah L Baines; Margot J Shumaker; Carol Samel; Mohammad Jubair; David A Pegues; Michael Z David
Journal:  Front Microbiol       Date:  2021-08-18       Impact factor: 6.064

3.  Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents.

Authors:  Antonio Torrelo; Ramon Grimalt; Xavier Masramon; Núria Albareda López; Ilonka Zsolt
Journal:  Dermatology       Date:  2020-01-20       Impact factor: 5.366

4.  Analysis of antibiotics resistant genes in different strains of Staphylococcus aureus.

Authors:  Benson Otarigho; Mofolusho O Falade
Journal:  Bioinformation       Date:  2018-03-31

5.  Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistance.

Authors:  Fan Zhang; Bing Bai; Guang-Jian Xu; Zhi-Wei Lin; Gui-Qiu Li; Zhong Chen; Hang Cheng; Xiang Sun; Hong-Yan Wang; Yan-Wei Chen; Jin-Xin Zheng; Qi-Wen Deng; Zhi-Jian Yu
Journal:  BMC Microbiol       Date:  2018-12-13       Impact factor: 3.605

6.  The global prevalence of fusidic acid resistance in clinical isolates of Staphylococcus aureus: a systematic review and meta-analysis.

Authors:  Mehdi Goudarzi; Bahareh Hajikhani; Sareh Kakavandi; Sana Amini; Samira Zamani; Alex van Belkum; Hossein Goudarzi; Masoud Dadashi
Journal:  Antimicrob Resist Infect Control       Date:  2021-05-01       Impact factor: 6.454

7.  Mupirocin-Resistant Staphylococcus aureus in Iran: A Biofilm Production and Genetic Characteristics.

Authors:  Samira Zamani; Anis Mohammadi; Bahareh Hajikhani; Parnaz Abiri; Maryam Fazeli; Mohammad Javad Nasiri; Masoud Dadashi; Mehdi Goudarzi; Mehrdad Haghighi
Journal:  Biomed Res Int       Date:  2022-01-15       Impact factor: 3.411

8.  Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial.

Authors:  Anne Weiss; Emilie Delavenne; Carina Matias; Heimo Lagler; Daniel Simon; Ping Li; Jon U Hansen; Teresa Pires Dos Santos; Bimal Jana; Petra Priemel; Christine Bangert; Martin Bauer; Sabine Eberl; Alina Nussbaumer-Pröll; Zoe Anne Österreicher; Peter Matzneller; Tamara Quint; Maria Weber; Hanne Mørck Nielsen; Thomas Rades; Helle Krogh Johansen; Henrik Westh; Wooseong Kim; Eleftherios Mylonakis; Christian Friis; Luca Guardabassi; John Pace; Carina Vingsbo Lundberg; Fatima M'Zali; Pascal Butty; Nikolaj Sørensen; Henrik Bjørn Nielsen; Rasmus Toft-Kehler; Emma Guttman-Yassky; Georg Stingl; Markus Zeitlinger; Morten Sommer
Journal:  Clin Transl Med       Date:  2022-05

9.  Emergence of a mupirocin-resistant, methicillin-susceptible Staphylococcus aureus clone associated with skin and soft tissue infections in Greece.

Authors:  Nikolaos Giormezis; Anastassios Doudoulakakis; Katerina Tsilipounidaki; Maria Militsopoulou; George Kalogeras; Vasiliki Stamouli; Fevronia Kolonitsiou; Efthimia Petinaki; Evangelia Lebessi; Iris Spiliopoulou
Journal:  BMC Microbiol       Date:  2021-07-03       Impact factor: 3.605

10.  Antibiotic-resistant profile and the factors affecting the intravenous antibiotic treatment course of generalized Staphylococcal Scalded Skin Syndrome: a retrospective study.

Authors:  Tao Yang; Jiangyi Wang; Junya Cao; Xinyue Zhang; Yun Lai; Longnian Li; Xiaoying Ye; Cong You
Journal:  Ital J Pediatr       Date:  2021-08-06       Impact factor: 2.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.